Global and Japan Methicillin-Susceptible Staphylococcus Aureus Market Size, Status and Forecast 2024-2031

Report ID: 1025258 | Published Date: Jan 2025 | No. of Page: 106 | Base Year: 2024 | Rating: 4.1 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
        1.2.2 Cephalosporins
        1.2.3 Vancomycin
        1.2.4 Linezolid
        1.2.5 Others
    1.3 Market by Application
        1.3.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Application: 2016 VS 2021 VS 2027
        1.3.2 Hospitals
        1.3.3 Clinics
        1.3.4 Others
    1.4 Study Objectives
    1.5 Years Considered

2 Global Growth Trends
    2.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Perspective (2016-2027)
    2.2 Methicillin-Susceptible Staphylococcus Aureus Growth Trends by Regions
        2.2.1 Methicillin-Susceptible Staphylococcus Aureus Market Size by Regions: 2016 VS 2021 VS 2027
        2.2.2 Methicillin-Susceptible Staphylococcus Aureus Historic Market Share by Regions (2016-2021)
        2.2.3 Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Regions (2022-2027)
    2.3 Methicillin-Susceptible Staphylococcus Aureus Industry Dynamic
        2.3.1 Methicillin-Susceptible Staphylococcus Aureus Market Trends
        2.3.2 Methicillin-Susceptible Staphylococcus Aureus Market Drivers
        2.3.3 Methicillin-Susceptible Staphylococcus Aureus Market Challenges
        2.3.4 Methicillin-Susceptible Staphylococcus Aureus Market Restraints

3 Competition Landscape by Key Players
    3.1 Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Revenue
        3.1.1 Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Revenue (2016-2021)
        3.1.2 Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Players (2016-2021)
    3.2 Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
    3.3 Players Covered: Ranking by Methicillin-Susceptible Staphylococcus Aureus Revenue
    3.4 Global Methicillin-Susceptible Staphylococcus Aureus Market Concentration Ratio
        3.4.1 Global Methicillin-Susceptible Staphylococcus Aureus Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Methicillin-Susceptible Staphylococcus Aureus Revenue in 2020
    3.5 Methicillin-Susceptible Staphylococcus Aureus Key Players Head office and Area Served
    3.6 Key Players Methicillin-Susceptible Staphylococcus Aureus Product Solution and Service
    3.7 Date of Enter into Methicillin-Susceptible Staphylococcus Aureus Market
    3.8 Mergers & Acquisitions, Expansion Plans

4 Methicillin-Susceptible Staphylococcus Aureus Breakdown Data by Type
    4.1 Global Methicillin-Susceptible Staphylococcus Aureus Historic Market Size by Type (2016-2021)
    4.2 Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Type (2022-2027)

5 Methicillin-Susceptible Staphylococcus Aureus Breakdown Data by Application
    5.1 Global Methicillin-Susceptible Staphylococcus Aureus Historic Market Size by Application (2016-2021)
    5.2 Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Application (2022-2027)

6 North America
    6.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
    6.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type
        6.2.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021)
        6.2.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027)
        6.2.3 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2027)
    6.3 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application
        6.3.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021)
        6.3.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027)
        6.3.3 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2027)
    6.4 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
        6.4.1 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
        6.4.2 North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
        6.4.3 United States
        6.4.4 Canada

7 Europe
    7.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
    7.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Type
        7.2.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021)
        7.2.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027)
        7.2.3 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2027)
    7.3 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Application
        7.3.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021)
        7.3.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027)
        7.3.3 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2027)
    7.4 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
        7.4.1 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
        7.4.2 Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
        7.4.3 Germany
        7.4.4 France
        7.4.5 U.K.
        7.4.6 Italy
        7.4.7 Russia
        7.4.8 Nordic

8 Asia-Pacific
    8.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
    8.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Type
        8.2.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021)
        8.2.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027)
        8.2.3 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2027)
    8.3 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Application
        8.3.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021)
        8.3.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027)
        8.3.3 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2027)
    8.4 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region
        8.4.1 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2016-2021)
        8.4.2 Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2022-2027)
        8.4.3 China
        8.4.4 Japan
        8.4.5 South Korea
        8.4.6 Southeast Asia
        8.4.7 India
        8.4.8 Australia

9 Latin America
    9.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
    9.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type
        9.2.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021)
        9.2.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027)
        9.2.3 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2027)
    9.3 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application
        9.3.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021)
        9.3.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027)
        9.3.3 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2027)
    9.4 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
        9.4.1 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
        9.4.2 Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
        9.4.3 Mexico
        9.4.4 Brazil

10 Middle East & Africa
    10.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size (2016-2027)
    10.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Type
        10.2.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021)
        10.2.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027)
        10.2.3 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2027)
    10.3 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Application
        10.3.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021)
        10.3.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027)
        10.3.3 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2027)
    10.4 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country
        10.4.1 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021)
        10.4.2 Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027)
        10.4.3 Turkey
        10.4.4 Saudi Arabia
        10.4.5 UAE

11 Key Players Profiles
    11.1 Dainippon Sumitomo Pharma Co., Ltd
        11.1.1 Dainippon Sumitomo Pharma Co., Ltd Company Details
        11.1.2 Dainippon Sumitomo Pharma Co., Ltd Business Overview
        11.1.3 Dainippon Sumitomo Pharma Co., Ltd Methicillin-Susceptible Staphylococcus Aureus Introduction
        11.1.4 Dainippon Sumitomo Pharma Co., Ltd Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
        11.1.5 Dainippon Sumitomo Pharma Co., Ltd Recent Development
    11.2 Immtech Pharmaceuticals, Inc.
        11.2.1 Immtech Pharmaceuticals, Inc. Company Details
        11.2.2 Immtech Pharmaceuticals, Inc. Business Overview
        11.2.3 Immtech Pharmaceuticals, Inc. Methicillin-Susceptible Staphylococcus Aureus Introduction
        11.2.4 Immtech Pharmaceuticals, Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
        11.2.5 Immtech Pharmaceuticals, Inc. Recent Development
    11.3 Lytix Biopharma AS
        11.3.1 Lytix Biopharma AS Company Details
        11.3.2 Lytix Biopharma AS Business Overview
        11.3.3 Lytix Biopharma AS Methicillin-Susceptible Staphylococcus Aureus Introduction
        11.3.4 Lytix Biopharma AS Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
        11.3.5 Lytix Biopharma AS Recent Development
    11.4 PharmaIN Corporation
        11.4.1 PharmaIN Corporation Company Details
        11.4.2 PharmaIN Corporation Business Overview
        11.4.3 PharmaIN Corporation Methicillin-Susceptible Staphylococcus Aureus Introduction
        11.4.4 PharmaIN Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
        11.4.5 PharmaIN Corporation Recent Development
    11.5 Cubist Pharmaceuticals
        11.5.1 Cubist Pharmaceuticals Company Details
        11.5.2 Cubist Pharmaceuticals Business Overview
        11.5.3 Cubist Pharmaceuticals Methicillin-Susceptible Staphylococcus Aureus Introduction
        11.5.4 Cubist Pharmaceuticals Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
        11.5.5 Cubist Pharmaceuticals Recent Development
    11.6 Kenta Biotech AG
        11.6.1 Kenta Biotech AG Company Details
        11.6.2 Kenta Biotech AG Business Overview
        11.6.3 Kenta Biotech AG Methicillin-Susceptible Staphylococcus Aureus Introduction
        11.6.4 Kenta Biotech AG Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
        11.6.5 Kenta Biotech AG Recent Development
    11.7 Arsanis Biosciences GmbH
        11.7.1 Arsanis Biosciences GmbH Company Details
        11.7.2 Arsanis Biosciences GmbH Business Overview
        11.7.3 Arsanis Biosciences GmbH Methicillin-Susceptible Staphylococcus Aureus Introduction
        11.7.4 Arsanis Biosciences GmbH Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
        11.7.5 Arsanis Biosciences GmbH Recent Development
    11.8 Volcano Corporation
        11.8.1 Volcano Corporation Company Details
        11.8.2 Volcano Corporation Business Overview
        11.8.3 Volcano Corporation Methicillin-Susceptible Staphylococcus Aureus Introduction
        11.8.4 Volcano Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
        11.8.5 Volcano Corporation Recent Development
    11.9 Abbott Laboratories
        11.9.1 Abbott Laboratories Company Details
        11.9.2 Abbott Laboratories Business Overview
        11.9.3 Abbott Laboratories Methicillin-Susceptible Staphylococcus Aureus Introduction
        11.9.4 Abbott Laboratories Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
        11.9.5 Abbott Laboratories Recent Development
    11.10 AngioScore Inc.
        11.10.1 AngioScore Inc. Company Details
        11.10.2 AngioScore Inc. Business Overview
        11.10.3 AngioScore Inc. Methicillin-Susceptible Staphylococcus Aureus Introduction
        11.10.4 AngioScore Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
        11.10.5 AngioScore Inc. Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details
List of Tables
    Table 1. Global Methicillin-Susceptible Staphylococcus Aureus Market Size Growth Rate by Type (US$ Million):2016 VS 2021 VS 2027
    Table 2. Key Players of Cephalosporins
    Table 3. Key Players of Vancomycin
    Table 4. Key Players of Linezolid
    Table 5. Key Players of Others
    Table 6. Global Methicillin-Susceptible Staphylococcus Aureus Market Size Growth by Application (US$ Million): 2016 VS 2021 VS 2027
    Table 7. Global Methicillin-Susceptible Staphylococcus Aureus Market Size by Regions (US$ Million): 2016 VS 2021 VS 2027
    Table 8. Global Methicillin-Susceptible Staphylococcus Aureus Market Size by Regions (2016-2021) & (US$ Million)
    Table 9. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Regions (2016-2021)
    Table 10. Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Regions (2022-2027) & (US$ Million)
    Table 11. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Regions (2022-2027)
    Table 12. Methicillin-Susceptible Staphylococcus Aureus Market Trends
    Table 13. Methicillin-Susceptible Staphylococcus Aureus Market Drivers
    Table 14. Methicillin-Susceptible Staphylococcus Aureus Market Challenges
    Table 15. Methicillin-Susceptible Staphylococcus Aureus Market Restraints
    Table 16. Global Methicillin-Susceptible Staphylococcus Aureus Revenue by Players (2016-2021) & (US$ Million)
    Table 17. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Players (2016-2021)
    Table 18. Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Methicillin-Susceptible Staphylococcus Aureus as of 2020)
    Table 19. Ranking of Global Top Methicillin-Susceptible Staphylococcus Aureus Companies by Revenue (US$ Million) in 2020
    Table 20. Global 5 Largest Players Market Share by Methicillin-Susceptible Staphylococcus Aureus Revenue (CR5 and HHI) & (2016-2021)
    Table 21. Key Players Headquarters and Area Served
    Table 22. Key Players Methicillin-Susceptible Staphylococcus Aureus Product Solution and Service
    Table 23. Date of Enter into Methicillin-Susceptible Staphylococcus Aureus Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021) (US$ Million)
    Table 26. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Type (2016-2021)
    Table 27. Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Type (2022-2027) (US$ Million)
    Table 28. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Type (2022-2027) & (US$ Million)
    Table 29. Global Methicillin-Susceptible Staphylococcus Aureus Market Size Share by Application (2016-2021) & (US$ Million)
    Table 30. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Application (2016-2021)
    Table 31. Global Methicillin-Susceptible Staphylococcus Aureus Forecasted Market Size by Application (2022-2027) (US$ Million)
    Table 32. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Application (2022-2027) & (US$ Million)
    Table 33. North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021) (US$ Million)
    Table 34. North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027) & (US$ Million)
    Table 35. North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021) (US$ Million)
    Table 36. North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027) & (US$ Million)
    Table 37. North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021) & (US$ Million) 
    Table 38. North America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027) & (US$ Million) 
    Table 39. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021) (US$ Million)
    Table 40. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027) & (US$ Million)
    Table 41. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021) (US$ Million)
    Table 42. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027) & (US$ Million)
    Table 43. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021) & (US$ Million) 
    Table 44. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027) & (US$ Million) 
    Table 45. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021) (US$ Million)
    Table 46. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027) & (US$ Million)
    Table 47. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021) (US$ Million)
    Table 48. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027) & (US$ Million)
    Table 49. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2016-2021) & (US$ Million) 
    Table 50. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size by Region (2022-2027) & (US$ Million) 
    Table 51. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021) (US$ Million)
    Table 52. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027) & (US$ Million)
    Table 53. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021) (US$ Million)
    Table 54. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027) & (US$ Million)
    Table 55. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021) & (US$ Million) 
    Table 56. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027) & (US$ Million) 
    Table 57. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2016-2021) (US$ Million)
    Table 58. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Type (2022-2027) & (US$ Million)
    Table 59. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2016-2021) (US$ Million)
    Table 60. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Application (2022-2027) & (US$ Million)
    Table 61. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2016-2021) & (US$ Million) 
    Table 62. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size by Country (2022-2027) & (US$ Million) 
    Table 63. Dainippon Sumitomo Pharma Co., Ltd Company Details
    Table 64. Dainippon Sumitomo Pharma Co., Ltd Business Overview
    Table 65. Dainippon Sumitomo Pharma Co., Ltd Methicillin-Susceptible Staphylococcus Aureus Product
    Table 66. Dainippon Sumitomo Pharma Co., Ltd Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
    Table 67. Dainippon Sumitomo Pharma Co., Ltd Recent Development
    Table 68. Immtech Pharmaceuticals, Inc. Company Details
    Table 69. Immtech Pharmaceuticals, Inc. Business Overview
    Table 70. Immtech Pharmaceuticals, Inc. Methicillin-Susceptible Staphylococcus Aureus Product
    Table 71. Immtech Pharmaceuticals, Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
    Table 72. Immtech Pharmaceuticals, Inc. Recent Development
    Table 73. Lytix Biopharma AS Company Details
    Table 74. Lytix Biopharma AS Business Overview
    Table 75. Lytix Biopharma AS Methicillin-Susceptible Staphylococcus Aureus Product
    Table 76. Lytix Biopharma AS Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
    Table 77. Lytix Biopharma AS Recent Development
    Table 78. PharmaIN Corporation Company Details
    Table 79. PharmaIN Corporation Business Overview
    Table 80. PharmaIN Corporation Methicillin-Susceptible Staphylococcus Aureus Product
    Table 81. PharmaIN Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
    Table 82. PharmaIN Corporation Recent Development
    Table 83. Cubist Pharmaceuticals Company Details
    Table 84. Cubist Pharmaceuticals Business Overview
    Table 85. Cubist Pharmaceuticals Methicillin-Susceptible Staphylococcus Aureus Product
    Table 86. Cubist Pharmaceuticals Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
    Table 87. Cubist Pharmaceuticals Recent Development
    Table 88. Kenta Biotech AG Company Details
    Table 89. Kenta Biotech AG Business Overview
    Table 90. Kenta Biotech AG Methicillin-Susceptible Staphylococcus Aureus Product
    Table 91. Kenta Biotech AG Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
    Table 92. Kenta Biotech AG Recent Development
    Table 93. Arsanis Biosciences GmbH Company Details
    Table 94. Arsanis Biosciences GmbH Business Overview
    Table 95. Arsanis Biosciences GmbH Methicillin-Susceptible Staphylococcus Aureus Product
    Table 96. Arsanis Biosciences GmbH Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
    Table 97. Arsanis Biosciences GmbH Recent Development
    Table 98. Volcano Corporation Company Details
    Table 99. Volcano Corporation Business Overview
    Table 100. Volcano Corporation Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
    Table 101. Volcano Corporation Recent Development
    Table 102. Abbott Laboratories Company Details
    Table 103. Abbott Laboratories Business Overview
    Table 104. Abbott Laboratories Methicillin-Susceptible Staphylococcus Aureus Product
    Table 105. Abbott Laboratories Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
    Table 106. Abbott Laboratories Recent Development
    Table 107. AngioScore Inc. Company Details
    Table 108. AngioScore Inc. Business Overview
    Table 109. AngioScore Inc. Methicillin-Susceptible Staphylococcus Aureus Product
    Table 110. AngioScore Inc. Revenue in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021) & (US$ Million)
    Table 111. AngioScore Inc. Recent Development
    Table 112. Research Programs/Design for This Report
    Table 113. Key Data Information from Secondary Sources
    Table 114. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Type: 2020 VS 2027
    Figure 2. Cephalosporins Features
    Figure 3. Vancomycin Features
    Figure 4. Linezolid Features
    Figure 5. Others Features
    Figure 6. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Application: 2020 VS 2027
    Figure 7. Hospitals Case Studies
    Figure 8. Clinics Case Studies
    Figure 9. Others Case Studies
    Figure 10. Methicillin-Susceptible Staphylococcus Aureus Report Years Considered
    Figure 11. Global Methicillin-Susceptible Staphylococcus Aureus Market Size (US$ Million), Year-over-Year: 2016-2027
    Figure 12. Global Methicillin-Susceptible Staphylococcus Aureus Market Size (US$ Million), 2016 VS 2021 VS 2027
    Figure 13. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Regions: 2020 VS 2027
    Figure 14. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Regions (2022-2027)
    Figure 15. Global Methicillin-Susceptible Staphylococcus Aureus Market Share by Players in 2020
    Figure 16. Global Top Methicillin-Susceptible Staphylococcus Aureus Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Methicillin-Susceptible Staphylococcus Aureus as of 2020
    Figure 17. The Top 10 and 5 Players Market Share by Methicillin-Susceptible Staphylococcus Aureus Revenue in 2020
    Figure 18. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Type (2016-2021)
    Figure 19. Global Methicillin-Susceptible Staphylococcus Aureus Revenue Market Share by Type (2022-2027)
    Figure 20. North America Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 21. North America Methicillin-Susceptible Staphylococcus Aureus Market Share by Type (2016-2027)
    Figure 22. North America Methicillin-Susceptible Staphylococcus Aureus Market Share by Application (2016-2027)
    Figure 23. North America Methicillin-Susceptible Staphylococcus Aureus Market Share by Country (2016-2027)
    Figure 24. United States Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 25. Canada Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 26. Europe Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 27. Europe Methicillin-Susceptible Staphylococcus Aureus Market Share by Type (2016-2027)
    Figure 28. Europe Methicillin-Susceptible Staphylococcus Aureus Market Share by Application (2016-2027)
    Figure 29. Europe Methicillin-Susceptible Staphylococcus Aureus Market Share by Country (2016-2027)
    Figure 30. Germany Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 31. France Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 32. U.K. Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 33. Italy Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 34. Russia Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 35. Nordic Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 36. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 37. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Share by Type (2016-2027)
    Figure 38. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Share by Application (2016-2027)
    Figure 39. Asia-Pacific Methicillin-Susceptible Staphylococcus Aureus Market Share by Region (2016-2027)
    Figure 40. China Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 41. Japan Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 42. South Korea Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 43. Southeast Asia Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 44. India Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 45. Australia Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 46. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 47. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Share by Type (2016-2027)
    Figure 48. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Share by Application (2016-2027)
    Figure 49. Latin America Methicillin-Susceptible Staphylococcus Aureus Market Share by Country (2016-2027)
    Figure 50. Mexico Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 51. Brazil Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 52. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 53. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Share by Type (2016-2027)
    Figure 54. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Share by Application (2016-2027)
    Figure 55. Middle East & Africa Methicillin-Susceptible Staphylococcus Aureus Market Share by Country (2016-2027)
    Figure 56. Turkey Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 57. Saudi Arabia Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 58. UAE Methicillin-Susceptible Staphylococcus Aureus Market Size YoY Growth (2016-2027) & (US$ Million)
    Figure 59. Dainippon Sumitomo Pharma Co., Ltd Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
    Figure 60. Immtech Pharmaceuticals, Inc. Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
    Figure 61. Lytix Biopharma AS Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
    Figure 62. PharmaIN Corporation Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
    Figure 63. Cubist Pharmaceuticals Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
    Figure 64. Kenta Biotech AG Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
    Figure 65. Arsanis Biosciences GmbH Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
    Figure 66. Volcano Corporation Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
    Figure 67. Abbott Laboratories Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
    Figure 68. AngioScore Inc. Revenue Growth Rate in Methicillin-Susceptible Staphylococcus Aureus Business (2016-2021)
    Figure 69. Bottom-up and Top-down Approaches for This Report
    Figure 70. Data Triangulation
    Figure 71. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Dainippon Sumitomo Pharma Co., Ltd
Immtech Pharmaceuticals, Inc.
Lytix Biopharma AS
PharmaIN Corporation
Cubist Pharmaceuticals
Kenta Biotech AG
Arsanis Biosciences GmbH
Volcano Corporation
Abbott Laboratories
AngioScore Inc.
Frequently Asked Questions
Methicillin-Susceptible Staphylococcus Aureus report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Methicillin-Susceptible Staphylococcus Aureus report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Methicillin-Susceptible Staphylococcus Aureus report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports